National Stock Based Compensation from 2010 to 2024

NHI Stock

USD 68.83 0.54 0.78%

National Health's Stock Based Compensation is increasing with slightly volatile movements from year to year. Stock Based Compensation is predicted to flatten to about 3.4 M. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals

Stock Based Compensation

First Reported

2006-03-31

Previous Quarter

687 K

Current Value

670 K

Quarterly Volatility

989.6 K

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check National Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among National Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 36.5 M, Interest Expense of 58.3 M or Total Revenue of 170.8 M, as well as many indicators such as Price To Sales Ratio of 7.26, Dividend Yield of 0.0868 or PTB Ratio of 1.84. National financial statements analysis is a perfect complement when working with National Health Valuation or Volatility modules.

Check out the analysis of National Health Correlation against competitors.

Latest National Health's Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of National Health Investors over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. National Health's Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in National Health's overall financial position and show how it may be relating to other accounts over time.

Stock Based Compensation

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Stock Based Compensation

Timeline

National Stock Based Compensation Regression Statistics

	Arithmetic Mean	3,358,454
	Geometric Mean	2,100,439
	Coefficient Of Variation	69.34
	Mean Deviation	1,591,272
	Median	2,612,000
	Standard Deviation	2,328,731
	Sample Variance	5.4T
	Range	8.6M
	R-Value	0.66
	Mean Square Error	3.3T
	R-Squared	0.44
	Significance	0.01
	Slope	345,099
	Total Sum of Squares	75.9T

National Stock Based Compensation History

	2024	3.4 M
	2023	4.6 M
	2022	8.6 M
	2021	8.4 M
	2020	3.1 M
	2019	3.6 M
	2018	2.5 M

Other Fundumenentals of National Health Investors

Stock Based Compensation To Revenue

National Health Stock Based Compensation component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Total Liab	Net Receivables	Total Current Assets	Accounts Payable	Common Stock	Short Term Debt	Long Term Debt	Current Deferred Revenue	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Property Plant Equipment	Long Term Debt Total	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.99	0.93	-0.06	0.99	0.9	0.88	0.7	0.95	0.36	0.99	0.52	0.95	0.9	0.7	0.62	0.96	0.94	-0.54	0.45	0.57	0.58	0.24
Total Stockholder Equity	0.99		0.9	-0.06	0.96	0.89	0.87	0.69	0.94	0.31	0.95	0.46	0.94	0.88	0.67	0.6	0.95	0.92	-0.51	0.44	0.53	0.57	0.23
Net Debt	0.93	0.9		0.17	0.94	0.91	0.87	0.84	0.89	0.36	0.96	0.55	0.97	0.91	0.71	0.61	0.98	0.99	-0.6	0.46	0.41	0.68	0.4
Retained Earnings	-0.06	-0.06	0.17		-0.06	0.13	0.1	0.6	0.2	-0.11	-0.03	-0.03	0.2	0.29	0.09	0.26	0.19	0.24	-0.22	0.21	-0.5	0.17	0.87
Total Liab	0.99	0.96	0.94	-0.06		0.9	0.87	0.69	0.93	0.38	1.0	0.57	0.95	0.89	0.71	0.64	0.96	0.94	-0.54	0.44	0.59	0.59	0.23
Net Receivables	0.9	0.89	0.91	0.13	0.9		0.99	0.8	0.9	0.4	0.91	0.65	0.93	0.92	0.81	0.83	0.91	0.93	-0.78	0.58	0.55	0.82	0.47
Total Current Assets	0.88	0.87	0.87	0.1	0.87	0.99		0.77	0.89	0.44	0.88	0.63	0.91	0.9	0.8	0.85	0.87	0.89	-0.81	0.65	0.56	0.84	0.47
Accounts Payable	0.7	0.69	0.84	0.6	0.69	0.8	0.77		0.82	0.33	0.72	0.38	0.86	0.89	0.59	0.67	0.85	0.88	-0.64	0.52	0.04	0.64	0.76
Common Stock	0.95	0.94	0.89	0.2	0.93	0.9	0.89	0.82		0.35	0.93	0.44	0.96	0.97	0.67	0.74	0.96	0.94	-0.6	0.53	0.4	0.57	0.49
Short Term Debt	0.36	0.31	0.36	-0.11	0.38	0.4	0.44	0.33	0.35		0.39	0.28	0.34	0.43	0.55	0.53	0.34	0.37	-0.51	0.7	0.31	0.38	0.16
Long Term Debt	0.99	0.95	0.96	-0.03	1.0	0.91	0.88	0.72	0.93	0.39		0.58	0.96	0.9	0.72	0.65	0.97	0.96	-0.56	0.46	0.57	0.61	0.26
Current Deferred Revenue	0.52	0.46	0.55	-0.03	0.57	0.65	0.63	0.38	0.44	0.28	0.58		0.52	0.47	0.82	0.61	0.49	0.55	-0.61	0.3	0.72	0.71	0.26
Net Tangible Assets	0.95	0.94	0.97	0.2	0.95	0.93	0.91	0.86	0.96	0.34	0.96	0.52		0.96	0.7	0.7	0.99	0.99	-0.62	0.52	0.41	0.67	0.47
Capital Surpluse	0.9	0.88	0.91	0.29	0.89	0.92	0.9	0.89	0.97	0.43	0.9	0.47	0.96		0.67	0.81	0.95	0.95	-0.68	0.58	0.32	0.64	0.58
Deferred Long Term Liab	0.7	0.67	0.71	0.09	0.71	0.81	0.8	0.59	0.67	0.55	0.72	0.82	0.7	0.67		0.74	0.68	0.73	-0.79	0.64	0.71	0.82	0.43
Long Term Investments	0.62	0.6	0.61	0.26	0.64	0.83	0.85	0.67	0.74	0.53	0.65	0.61	0.7	0.81	0.74		0.63	0.68	-0.88	0.69	0.45	0.76	0.63
Property Plant Equipment	0.96	0.95	0.98	0.19	0.96	0.91	0.87	0.85	0.96	0.34	0.97	0.49	0.99	0.95	0.68	0.63		0.99	-0.56	0.47	0.39	0.61	0.42
Long Term Debt Total	0.94	0.92	0.99	0.24	0.94	0.93	0.89	0.88	0.94	0.37	0.96	0.55	0.99	0.95	0.73	0.68	0.99		-0.63	0.51	0.41	0.69	0.48
Short Long Term Debt	-0.54	-0.51	-0.6	-0.22	-0.54	-0.78	-0.81	-0.64	-0.6	-0.51	-0.56	-0.61	-0.62	-0.68	-0.79	-0.88	-0.56	-0.63		-0.65	-0.44	-0.89	-0.55
Cash And Equivalents	0.45	0.44	0.46	0.21	0.44	0.58	0.65	0.52	0.53	0.7	0.46	0.3	0.52	0.58	0.64	0.69	0.47	0.51	-0.65		0.39	0.67	0.59
Net Invested Capital	0.57	0.53	0.41	-0.5	0.59	0.55	0.56	0.04	0.4	0.31	0.57	0.72	0.41	0.32	0.71	0.45	0.39	0.41	-0.44	0.39		0.57	-0.13
Net Working Capital	0.58	0.57	0.68	0.17	0.59	0.82	0.84	0.64	0.57	0.38	0.61	0.71	0.67	0.64	0.82	0.76	0.61	0.69	-0.89	0.67	0.57		0.53
Capital Stock	0.24	0.23	0.4	0.87	0.23	0.47	0.47	0.76	0.49	0.16	0.26	0.26	0.47	0.58	0.43	0.63	0.42	0.48	-0.55	0.59	-0.13	0.53

Click cells to compare fundamentals

About National Health Financial Statements

Investors use fundamental indicators, such as National Health's Stock Based Compensation, to determine how well the company is positioned to perform in the future. Although National Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.

	Last Reported	Projected for Next Year
Stock Based Compensation	4.6 M	3.4 M
Stock Based Compensation To Revenue	0.01	0.01

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

When determining whether National Health Investors offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Health Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Health Investors Stock:

How To Invest In National

Details

Is National Stock a good investment?

Details

What is National Health's Net Worth?

Details

Largest Diversified REITs Companies

View

Largest Equity Real Estate Investment Trusts (REITs) Companies

View

Check out the analysis of National Health Correlation against competitors.

You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Health. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.14)

Dividend Share

3.6

Earnings Share

2.91

Revenue Per Share

7.598

Quarterly Revenue Growth

(0.12)

The market value of National Health Investors is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Health's value that differs from its market value or its book value, called intrinsic value, which is National Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Health's market value can be influenced by many factors that don't directly affect National Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between National Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

National Stock Based Compensation from 2010 to 2024

Latest National Health's Stock Based Compensation Growth Pattern

National Stock Based Compensation Regression Statistics

National Stock Based Compensation History

Other Fundumenentals of National Health Investors

National Health Stock Based Compensation component correlations

About National Health Financial Statements

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY